Bliss GVS Pharma Half Yearly Results

FINANCIALS

Select Period:

Particulars ( Rupees In Crores.)	Mar-2023	Sep-2022	Mar-2022	Sep-2021	Mar-2021
Gross Sales	390.50	361.09	383.32	364.13	296.11
Excise Duty	--	--	--	--	--
Net Sales	390.50	361.09	383.32	364.13	296.11
Other Operating Income	--	--	--	--	--
Other Income	8.62	9.16	18.22	13.27	10.44
Total Income	399.12	370.25	401.55	377.40	306.56
Total Expenditure	336.57	297.70	402.58	300.12	241.07
PBIDT	62.55	72.56	(1.04)	77.28	65.49
Interest	6.35	4.02	2.67	2.07	3.19
PBDT	56.21	68.54	(3.71)	75.20	62.30
Depreciation	9.52	9.15	8.70	8.63	8.63
Minority Interest Before NP	--	--	--	--	--
Tax	19.34	21.51	14.26	21.53	16.79
Deferred Tax	(5.91)	(5.60)	(1.60)	(3.14)	1.17
Reported Profit After Tax	33.25	43.48	(25.06)	48.19	35.71
Minority Interest After NP	1.97	3.91	5.42	2.67	3.92
Net Profit after Minority Interest	31.29	39.57	(30.48)	45.52	31.79
Extra-ordinary Items	--	--	(73.59)	--	--
Adjusted Profit After Extra-ordinary item	31.29	39.57	43.11	45.52	31.79
EPS (Unit Curr.)	3	3.81	--	4.40	3.08
Book Value (Unit Curr.)	--	--	--	--	--
Dividend (%)	--	--	--	--	--
Equity	10.42	10.37	10.37	10.35	10.31
Public Shareholding (Number)	--	--	--	--	--
Public Shareholding (%)	--	--	--	--	--
Pledged/Encumbered - No. of Shares	--	--	--	--	--
Pledged/Encumbered - % in Total Promoters Holding	--	--	--	--	--
Pledged/Encumbered - % in Total Equity	--	--	--	--	--
Non Encumbered - No. of Shares	--	--	--	--	--
Non Encumbered - % in Total Promoters Holding	--	--	--	--	--
Non Encumbered - % in Total Equity	--	--	--	--	--
PBIDTM(%)	16.02	20.09	(0.27)	21.22	22.12
PBDTM(%)	--	--	--	--	--
PATM(%)	8.52	12.04	(6.54)	13.23	12.06

QuickLinks for Bliss GVS Pharma Ltd.